Motivated by a career-ending ligament tear, a former NFL player starts a company to test athletes' genetic predispositions to common sports injuries.
Motivated by a career-ending ligament tear, a former NFL player starts a company to test athletes' genetic predispositions to common sports injuries.
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
A transcription factor can make adult stem cells behave like fetal stem cells.
An antibody that binds 16 different flu viruses offers hope for the long-sought universal vaccine.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
New data suggest that optimism may lower the risk of stroke.